Clarification2 Nov 2026, 05:10 pm
Symbiox Investment: No fund utilization deviation for Q2 FY27
AI Summary
Symbiox Investment & Trading Company Ltd has confirmed the non-applicability of the Statement of Deviation or Variation in Utilisation of Funds under Regulation 32 of SEBI (LODR) Regulations, 2015, for the quarter ended September 30, 2026. The company stated that it has not raised any funds through public issue, rights issue, preferential issue, or qualified institutional placement (QIP) during the specified quarter. Consequently, the requirement to submit a statement detailing any deviation or variation in the utilization of such funds does not apply.
Key Highlights
- Company confirms non-applicability of SEBI LODR Regulation 32.
- No funds were raised via public, rights, or preferential issues.
- No QIPs were conducted in the quarter ended September 30, 2026.
- This filing is a regulatory confirmation.
Price Impact
More from SYMBIOX